Clinical Trial Update: Phase II Prospective Trial of Addition of Rituximab to Reduced Dose CHOP Chemotherapy in DLBC L Patients Aged 65 Years and Over [Phase 2]

View source ↗

Summary

Phase II trial evaluating the addition of rituximab to a reduced-dose CHOP regimen in elderly patients with diffuse large B-cell lymphoma; current status is unk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• Vincristine (vincristine)

Snippet

Sponsor: Pusan National University Hospital | Conditions: Diffuse Large B-cell Lymphoma | Phase 2 | Status: UNKNOWN